165 related articles for article (PubMed ID: 23291438)
1. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
[TBL] [Abstract][Full Text] [Related]
2. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
4. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
[TBL] [Abstract][Full Text] [Related]
5. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.
MacCallum J; Cummings J; Dixon JM; Miller WR
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):317-23. PubMed ID: 8738037
[TBL] [Abstract][Full Text] [Related]
7. Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial.
Lee KH; Ward BA; Desta Z; Flockhart DA; Jones DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):245-53. PubMed ID: 12798184
[TBL] [Abstract][Full Text] [Related]
8. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
[TBL] [Abstract][Full Text] [Related]
9. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
[TBL] [Abstract][Full Text] [Related]
10. Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients.
Maggadani BP; Harmita ; Haryono SJ; Rinaldi MR; Harahap Y
Drug Des Devel Ther; 2021; 15():2417-2430. PubMed ID: 34113081
[TBL] [Abstract][Full Text] [Related]
11. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
[TBL] [Abstract][Full Text] [Related]
13. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
[TBL] [Abstract][Full Text] [Related]
14. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
[TBL] [Abstract][Full Text] [Related]
15. Optimised separation of E- and Z- isomers of tamoxifen, and its principal metabolites using reversed-phase high performance liquid chromatography.
Manns JE; Hanks S; Brown JE
J Pharm Biomed Anal; 1998 Jan; 16(5):847-52. PubMed ID: 9535197
[TBL] [Abstract][Full Text] [Related]
16. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of tamoxifen and its four major metabolites in plasma using coupled column high-performance liquid chromatography.
Fried KM; Wainer IW
J Chromatogr B Biomed Appl; 1994 May; 655(2):261-8. PubMed ID: 8081472
[TBL] [Abstract][Full Text] [Related]
18. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
[TBL] [Abstract][Full Text] [Related]
19. Fast and Adequate Liquid Chromatography-Tandem Mass Spectrometric Determination of Z-endoxifen Serum Levels for Therapeutic Drug Monitoring.
de Krou S; Rosing H; Nuijen B; Schellens JH; Beijnen JH
Ther Drug Monit; 2017 Apr; 39(2):132-137. PubMed ID: 28045782
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in breast tumour tissues.
MacCallum J; Cummings J; Dixon JM; Miller WR
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):269-75. PubMed ID: 9367217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
